HORIZON-MISS-2027-02-CANCER-01: Leveraging functional genomics to reveal novel targets for cancer treatment (RIA)

HORIZON-MISS-2027-02-CANCER-02: Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers (IA)

HORIZON-MISS-2027-02-CANCER-03: Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multimodal treatment interventions for patients with rare or very rare cancers or cancer subtypes (RIA)

HORIZON-MISS-2027-02-CANCER-04: Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research (RIA)

HORIZON-MISS-2027-02-CANCER-05: Precommercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines (PCP)

HORIZON-MISS-2027-02-CANCER-06: Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies (CSA)

The call opens on 10th February 2027

HORIZON-MISS-2027-06-SOIL-CANCER: Living labs to monitor and mitigate carcinogenic substances in and originating from soils: Evaluating their effects on human cancer risks (RIA)

The call opens on 4th February 2027

HORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicine (RIA)

HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis (RIA)

HORIZON-HLTH-2027-03-TOOL-08: Towards Artificial General Intelligence (AGI) for healthcare (CSA)

The call opens on 3rd June 2027 

HORIZON-HLTH-2026-03-DISEASE-13: European Partnership for Pandemic Preparedness (Phase 2) (Programme Cofund Actions)

The call opens on 10th February 2027. 

HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics (IA)

The call opens on 29th October 2026

Deadline of second stage is 16th September 2027

HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications (RIA)

The call opens on 29th October 2026 

HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential (RIA)

HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses (RIA)

HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses (RIA)

HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials (RIA)

HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD) (RIA)

The call opens on 29th October 2026 

HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change (RIA)

HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change (PCP)

The call opens on 29th October 2026. 

HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases (RIA)

• The call opens on 29th October  2026 
• Deadline for 1st stage proposals is 17th February 2027
• Deadline for 2nd stage proposals is 16th September 2027

HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases (RIA)

HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseases (RIA)

• The call opens on 29th October 2026 
• Deadline of first stage is 17th February 2027
• Deadline for second stage is 16th September 

HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion (RIA)The call opens on 10th February 2026 

The call opens on 29th October 2026 

HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals (RIA)

The call opens on 29th October 2026

The Paediatric clinical Research Infrastructure Service Model (PRISM) project aims to transform paediatric clinical research in Europe and Canada by creating a coordinated, transnational ecosystem of experienced infrastructures and service organisations. PRISM will deliver high-quality, innovative and sustainable clinical research support tailored for children and young people. 

The call will open in mid-September 2026

Applicants to this Challenge will be expected to develop a proof of concept in one of the following three areas:

• An innovative preventative or therapeutic biotechnology-based or pharmaceutical intervention

• A biomarker based tool

• A New Approach Methodology (NAM)

MCSC Hospital Leadership Innovation is an international competition organized by the Institute of Mother and Child, supported by a network of hospitals from across Poland. Its goal is to identify and support the development of breakthrough solutions that set new standards in healthcare and medical facility management.

MCSC creates a dynamic ecosystem of collaboration between hospitals, academia, and technology partners — enabling rapid testing, implementation, and scaling of modern solutions that meet the current needs of the healthcare system.